Compare MDCXW & HAVAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDCXW | HAVAR |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | South Korea |
| Employees | 12 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2025 |
| Metric | MDCXW | HAVAR |
|---|---|---|
| Price | $0.81 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.0K | N/A |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.12 | N/A |
| 52 Week High | $1.34 | N/A |
| Indicator | MDCXW | HAVAR |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | N/A |
| Support Level | $0.93 | N/A |
| Resistance Level | $0.82 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 13.56 | 0.00 |
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.